IDACIO

ADALIMUMAB-AACF · Fresenius Kabi USA, LLC

Drug timelines are a Plus or Pro feature.

12 regulatory and trial events tracked for IDACIO, covering 2022-12-13 to 2026-08-06. Get the full timeline:

Most recent: EMA Authorised: Idacio (adalimumab) — Fresenius Kabi Deutschland GmbH